Marketing of unproven stem cell–based interventions: A call to action
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Marketing of unproven stem cell–based interventions: A call to action
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 397, Pages eaag0426
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-10-13
DOI
10.1126/scitranslmed.aag0426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Distribution of Businesses Marketing Stem Cell-Based Interventions
- (2016) Israel Berger et al. Cell Stem Cell
- Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
- (2016) Leigh Turner et al. Cell Stem Cell
- Part 1: Defining unproven cellular therapies
- (2016) Alok Srivastava et al. CYTOTHERAPY
- On the Road (to a Cure?) — Stem-Cell Tourism and Lessons for Gene Editing
- (2016) R. Alta Charo NEW ENGLAND JOURNAL OF MEDICINE
- The current status of clinics providing private practice cell therapy in Japan
- (2016) Misao Fujita et al. Regenerative Medicine
- Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations
- (2016) Achim Rosemann et al. Regenerative Medicine
- New regulation for clinical stem cell research in China: expected impact and challenges for implementation
- (2016) Achim Rosemann et al. Regenerative Medicine
- Under 21st Century Cures legislation, stem cell advocates expect regulatory shortcuts
- (2016) Kelly Servick SCIENCE
- Confronting stem cell hype
- (2016) T. Caulfield et al. SCIENCE
- Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines
- (2016) George Q. Daley et al. Stem Cell Reports
- The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications
- (2015) Tim K. Mackey et al. BMC HEALTH SERVICES RESEARCH
- Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products
- (2015) Douglas Sipp Cell Stem Cell
- Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective
- (2015) Massimo Dominici et al. CYTOTHERAPY
- Medicine's Wild West — Unlicensed Stem-Cell Clinics in the United States
- (2015) Hermes Taylor-Weiner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
- (2015) Alison K McLean et al. Stem Cell Research & Therapy
- Stem cells: Taking a stand against pseudoscience
- (2014) Elena Cattaneo et al. NATURE
- Stem cell tourism – A web-based analysis of clinical services available to international travellers
- (2014) Ruairi Connolly et al. Travel Medicine and Infectious Disease
- Regulation of stem cell therapies under attack in Europe: for whom the bell tolls
- (2013) Paolo Bianco et al. EMBO JOURNAL
- Stem Cells, Dot-Com
- (2012) B. A. Liang et al. Science Translational Medicine
- Stem cell stratagems in alternative medicine
- (2011) Douglas Sipp Regenerative Medicine
- ASAPS/ASPS Position Statement on Stem Cells and Fat Grafting
- (2011) Aesthetic Surgery Journal
- Stem cell clinics in the news
- (2010) Amy Zarzeczny et al. NATURE BIOTECHNOLOGY
- Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine
- (2008) Darren Lau et al. Cell Stem Cell
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started